A bone paradigm challenging the standard model of myeloma oncogenesis

Crit Rev Oncol Hematol. 2022 Apr:172:103640. doi: 10.1016/j.critrevonc.2022.103640. Epub 2022 Feb 18.

Abstract

The standard model of multiple myeloma (MM) oncogenesis from monoclonal gammopathy of undetermined significance (MGUS) relies on genetic instability in the normal counterparts of MM cells. However, the importance of both MGUS-associated and MM-induced bone changes has been recently re-appraised, emphasizing the bone microenvironment (BME) as a tissue of significance. In this review, we propose that early BME alterations (bone senescence and inflammation, i.e., bone inflamm'aging) at the pre-MGUS stage could be causal, and not simply permissive, and creative of phenotypic instability and genetic alterations thanks to the concept of tissue disruption-induced cell stochasticity (TiDiS). This article offers a bone scenario challenging the chromosome-and-gene-centric standard model of MM oncogenesis. The high incidence of both MGUS and MM in Gaucher disease supports such a scenario.

Keywords: Bone inflamm'aging; Bone marrow microenvironment; Endosteal niche; Gaucher disease; Mesenchymal-stromal to osteoblast transition (MS-to-ObT); Monoclonal gammopathy of undetermined significance; Multiple myeloma; Tissue disruption-induced cellular stochasticity (TiDiS).

Publication types

  • Review

MeSH terms

  • Cell Transformation, Neoplastic / genetics
  • Humans
  • Monoclonal Gammopathy of Undetermined Significance* / epidemiology
  • Monoclonal Gammopathy of Undetermined Significance* / genetics
  • Multiple Myeloma* / genetics
  • Paraproteinemias*
  • Tumor Microenvironment